nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—CYP2D6—Lomustine—hematologic cancer	0.05	0.189	CbGbCtD
Quinidine barbiturate—CYP2D6—Idarubicin—hematologic cancer	0.0445	0.168	CbGbCtD
Quinidine barbiturate—CYP2D6—Hydroxyurea—hematologic cancer	0.0379	0.143	CbGbCtD
Quinidine barbiturate—CYP2D6—Bortezomib—hematologic cancer	0.0329	0.124	CbGbCtD
Quinidine barbiturate—CYP2D6—Imatinib—hematologic cancer	0.0241	0.0912	CbGbCtD
Quinidine barbiturate—CYP2D6—Nilotinib—hematologic cancer	0.0219	0.0829	CbGbCtD
Quinidine barbiturate—CYP2D6—Vinorelbine—hematologic cancer	0.0217	0.0822	CbGbCtD
Quinidine barbiturate—CYP2D6—Vinblastine—hematologic cancer	0.0134	0.0506	CbGbCtD
Quinidine barbiturate—CYP2D6—Dexamethasone—hematologic cancer	0.00993	0.0375	CbGbCtD
Quinidine barbiturate—CYP2D6—Doxorubicin—hematologic cancer	0.00824	0.0311	CbGbCtD
Quinidine barbiturate—Quinine—SLC22A1—hematologic cancer	0.00223	0.321	CrCbGaD
Quinidine barbiturate—Quinidine—SLC22A1—hematologic cancer	0.00196	0.282	CrCbGaD
Quinidine barbiturate—Phenobarbital—ABCC3—hematologic cancer	0.00128	0.184	CrCbGaD
Quinidine barbiturate—Quinine—ABCB1—hematologic cancer	0.000649	0.0934	CrCbGaD
Quinidine barbiturate—Quinidine—ABCB1—hematologic cancer	0.00057	0.0821	CrCbGaD
Quinidine barbiturate—Phenobarbital—ABCB1—hematologic cancer	0.000258	0.0372	CrCbGaD
Quinidine barbiturate—Erythema—Methotrexate—hematologic cancer	5.53e-05	9.26e-05	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Doxorubicin—hematologic cancer	5.53e-05	9.26e-05	CcSEcCtD
Quinidine barbiturate—Headache—Gemcitabine—hematologic cancer	5.53e-05	9.26e-05	CcSEcCtD
Quinidine barbiturate—Nausea—Vincristine—hematologic cancer	5.52e-05	9.26e-05	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Epirubicin—hematologic cancer	5.51e-05	9.24e-05	CcSEcCtD
Quinidine barbiturate—Flushing—Epirubicin—hematologic cancer	5.51e-05	9.24e-05	CcSEcCtD
Quinidine barbiturate—Hepatitis—Doxorubicin—hematologic cancer	5.5e-05	9.22e-05	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Doxorubicin—hematologic cancer	5.5e-05	9.22e-05	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Prednisolone—hematologic cancer	5.47e-05	9.17e-05	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Doxorubicin—hematologic cancer	5.43e-05	9.1e-05	CcSEcCtD
Quinidine barbiturate—Urticaria—Triamcinolone—hematologic cancer	5.43e-05	9.1e-05	CcSEcCtD
Quinidine barbiturate—Asthenia—Etoposide—hematologic cancer	5.4e-05	9.06e-05	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Triamcinolone—hematologic cancer	5.4e-05	9.05e-05	CcSEcCtD
Quinidine barbiturate—Oedema—Prednisone—hematologic cancer	5.4e-05	9.05e-05	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Doxorubicin—hematologic cancer	5.39e-05	9.03e-05	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Betamethasone—hematologic cancer	5.39e-05	9.03e-05	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Dexamethasone—hematologic cancer	5.39e-05	9.03e-05	CcSEcCtD
Quinidine barbiturate—Nausea—Irinotecan—hematologic cancer	5.38e-05	9.01e-05	CcSEcCtD
Quinidine barbiturate—Nausea—Mitoxantrone—hematologic cancer	5.38e-05	9.01e-05	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Epirubicin—hematologic cancer	5.37e-05	9e-05	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Epirubicin—hematologic cancer	5.36e-05	8.98e-05	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.35e-05	8.97e-05	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.35e-05	8.97e-05	CcSEcCtD
Quinidine barbiturate—Chills—Epirubicin—hematologic cancer	5.33e-05	8.94e-05	CcSEcCtD
Quinidine barbiturate—Pruritus—Etoposide—hematologic cancer	5.33e-05	8.93e-05	CcSEcCtD
Quinidine barbiturate—Shock—Prednisone—hematologic cancer	5.31e-05	8.9e-05	CcSEcCtD
Quinidine barbiturate—Pain—Dexamethasone—hematologic cancer	5.3e-05	8.88e-05	CcSEcCtD
Quinidine barbiturate—Pain—Betamethasone—hematologic cancer	5.3e-05	8.88e-05	CcSEcCtD
Quinidine barbiturate—Visual impairment—Doxorubicin—hematologic cancer	5.3e-05	8.88e-05	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Prednisone—hematologic cancer	5.29e-05	8.87e-05	CcSEcCtD
Quinidine barbiturate—Tachycardia—Prednisone—hematologic cancer	5.27e-05	8.83e-05	CcSEcCtD
Quinidine barbiturate—Skin disorder—Prednisone—hematologic cancer	5.24e-05	8.79e-05	CcSEcCtD
Quinidine barbiturate—Nausea—Gemcitabine—hematologic cancer	5.24e-05	8.78e-05	CcSEcCtD
Quinidine barbiturate—Vomiting—Cisplatin—hematologic cancer	5.23e-05	8.76e-05	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Prednisone—hematologic cancer	5.22e-05	8.75e-05	CcSEcCtD
Quinidine barbiturate—Vision blurred—Methotrexate—hematologic cancer	5.21e-05	8.73e-05	CcSEcCtD
Quinidine barbiturate—Mental disorder—Epirubicin—hematologic cancer	5.21e-05	8.73e-05	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Doxorubicin—hematologic cancer	5.2e-05	8.71e-05	CcSEcCtD
Quinidine barbiturate—Rash—Cisplatin—hematologic cancer	5.18e-05	8.69e-05	CcSEcCtD
Quinidine barbiturate—Dermatitis—Cisplatin—hematologic cancer	5.18e-05	8.68e-05	CcSEcCtD
Quinidine barbiturate—Malnutrition—Epirubicin—hematologic cancer	5.17e-05	8.67e-05	CcSEcCtD
Quinidine barbiturate—Erythema—Epirubicin—hematologic cancer	5.17e-05	8.67e-05	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Etoposide—hematologic cancer	5.15e-05	8.64e-05	CcSEcCtD
Quinidine barbiturate—Anorexia—Prednisone—hematologic cancer	5.15e-05	8.62e-05	CcSEcCtD
Quinidine barbiturate—Eye disorder—Doxorubicin—hematologic cancer	5.14e-05	8.61e-05	CcSEcCtD
Quinidine barbiturate—Tinnitus—Doxorubicin—hematologic cancer	5.13e-05	8.59e-05	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Dexamethasone—hematologic cancer	5.11e-05	8.56e-05	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Betamethasone—hematologic cancer	5.11e-05	8.56e-05	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Doxorubicin—hematologic cancer	5.1e-05	8.55e-05	CcSEcCtD
Quinidine barbiturate—Flushing—Doxorubicin—hematologic cancer	5.1e-05	8.55e-05	CcSEcCtD
Quinidine barbiturate—Tension—Epirubicin—hematologic cancer	5.08e-05	8.51e-05	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.07e-05	8.5e-05	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Betamethasone—hematologic cancer	5.07e-05	8.5e-05	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Triamcinolone—hematologic cancer	5.03e-05	8.44e-05	CcSEcCtD
Quinidine barbiturate—Nervousness—Epirubicin—hematologic cancer	5.02e-05	8.42e-05	CcSEcCtD
Quinidine barbiturate—Dizziness—Etoposide—hematologic cancer	4.98e-05	8.35e-05	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Doxorubicin—hematologic cancer	4.97e-05	8.32e-05	CcSEcCtD
Quinidine barbiturate—Vertigo—Methotrexate—hematologic cancer	4.97e-05	8.32e-05	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Doxorubicin—hematologic cancer	4.95e-05	8.31e-05	CcSEcCtD
Quinidine barbiturate—Leukopenia—Methotrexate—hematologic cancer	4.95e-05	8.29e-05	CcSEcCtD
Quinidine barbiturate—Chills—Doxorubicin—hematologic cancer	4.93e-05	8.27e-05	CcSEcCtD
Quinidine barbiturate—Urticaria—Dexamethasone—hematologic cancer	4.92e-05	8.25e-05	CcSEcCtD
Quinidine barbiturate—Urticaria—Betamethasone—hematologic cancer	4.92e-05	8.25e-05	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.92e-05	8.24e-05	CcSEcCtD
Quinidine barbiturate—Dizziness—Prednisolone—hematologic cancer	4.91e-05	8.23e-05	CcSEcCtD
Quinidine barbiturate—Asthenia—Triamcinolone—hematologic cancer	4.9e-05	8.22e-05	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Dexamethasone—hematologic cancer	4.9e-05	8.21e-05	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Dexamethasone—hematologic cancer	4.9e-05	8.21e-05	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Betamethasone—hematologic cancer	4.9e-05	8.21e-05	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Betamethasone—hematologic cancer	4.9e-05	8.21e-05	CcSEcCtD
Quinidine barbiturate—Nausea—Cisplatin—hematologic cancer	4.88e-05	8.18e-05	CcSEcCtD
Quinidine barbiturate—Vision blurred—Epirubicin—hematologic cancer	4.87e-05	8.17e-05	CcSEcCtD
Quinidine barbiturate—Pruritus—Triamcinolone—hematologic cancer	4.83e-05	8.1e-05	CcSEcCtD
Quinidine barbiturate—Mental disorder—Doxorubicin—hematologic cancer	4.82e-05	8.07e-05	CcSEcCtD
Quinidine barbiturate—Convulsion—Methotrexate—hematologic cancer	4.79e-05	8.03e-05	CcSEcCtD
Quinidine barbiturate—Vomiting—Etoposide—hematologic cancer	4.79e-05	8.03e-05	CcSEcCtD
Quinidine barbiturate—Erythema—Doxorubicin—hematologic cancer	4.79e-05	8.02e-05	CcSEcCtD
Quinidine barbiturate—Malnutrition—Doxorubicin—hematologic cancer	4.79e-05	8.02e-05	CcSEcCtD
Quinidine barbiturate—Agitation—Epirubicin—hematologic cancer	4.75e-05	7.97e-05	CcSEcCtD
Quinidine barbiturate—Rash—Etoposide—hematologic cancer	4.75e-05	7.96e-05	CcSEcCtD
Quinidine barbiturate—Dermatitis—Etoposide—hematologic cancer	4.74e-05	7.95e-05	CcSEcCtD
Quinidine barbiturate—Headache—Etoposide—hematologic cancer	4.72e-05	7.91e-05	CcSEcCtD
Quinidine barbiturate—Arthralgia—Methotrexate—hematologic cancer	4.71e-05	7.89e-05	CcSEcCtD
Quinidine barbiturate—Chest pain—Methotrexate—hematologic cancer	4.71e-05	7.89e-05	CcSEcCtD
Quinidine barbiturate—Myalgia—Methotrexate—hematologic cancer	4.71e-05	7.89e-05	CcSEcCtD
Quinidine barbiturate—Tension—Doxorubicin—hematologic cancer	4.7e-05	7.87e-05	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Prednisone—hematologic cancer	4.69e-05	7.87e-05	CcSEcCtD
Quinidine barbiturate—Rash—Prednisolone—hematologic cancer	4.68e-05	7.85e-05	CcSEcCtD
Quinidine barbiturate—Dermatitis—Prednisolone—hematologic cancer	4.68e-05	7.84e-05	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.67e-05	7.83e-05	CcSEcCtD
Quinidine barbiturate—Headache—Prednisolone—hematologic cancer	4.65e-05	7.8e-05	CcSEcCtD
Quinidine barbiturate—Nervousness—Doxorubicin—hematologic cancer	4.65e-05	7.79e-05	CcSEcCtD
Quinidine barbiturate—Vertigo—Epirubicin—hematologic cancer	4.65e-05	7.79e-05	CcSEcCtD
Quinidine barbiturate—Syncope—Epirubicin—hematologic cancer	4.64e-05	7.78e-05	CcSEcCtD
Quinidine barbiturate—Leukopenia—Epirubicin—hematologic cancer	4.63e-05	7.76e-05	CcSEcCtD
Quinidine barbiturate—Constipation—Prednisone—hematologic cancer	4.62e-05	7.74e-05	CcSEcCtD
Quinidine barbiturate—Palpitations—Epirubicin—hematologic cancer	4.57e-05	7.66e-05	CcSEcCtD
Quinidine barbiturate—Confusional state—Methotrexate—hematologic cancer	4.55e-05	7.62e-05	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Epirubicin—hematologic cancer	4.55e-05	7.62e-05	CcSEcCtD
Quinidine barbiturate—Dizziness—Triamcinolone—hematologic cancer	4.52e-05	7.57e-05	CcSEcCtD
Quinidine barbiturate—Vision blurred—Doxorubicin—hematologic cancer	4.51e-05	7.56e-05	CcSEcCtD
Quinidine barbiturate—Convulsion—Epirubicin—hematologic cancer	4.48e-05	7.51e-05	CcSEcCtD
Quinidine barbiturate—Nausea—Etoposide—hematologic cancer	4.47e-05	7.5e-05	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Prednisone—hematologic cancer	4.45e-05	7.46e-05	CcSEcCtD
Quinidine barbiturate—Asthenia—Dexamethasone—hematologic cancer	4.45e-05	7.45e-05	CcSEcCtD
Quinidine barbiturate—Asthenia—Betamethasone—hematologic cancer	4.45e-05	7.45e-05	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Methotrexate—hematologic cancer	4.42e-05	7.42e-05	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Methotrexate—hematologic cancer	4.42e-05	7.4e-05	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Prednisone—hematologic cancer	4.41e-05	7.4e-05	CcSEcCtD
Quinidine barbiturate—Nausea—Prednisolone—hematologic cancer	4.41e-05	7.4e-05	CcSEcCtD
Quinidine barbiturate—Chest pain—Epirubicin—hematologic cancer	4.4e-05	7.38e-05	CcSEcCtD
Quinidine barbiturate—Arthralgia—Epirubicin—hematologic cancer	4.4e-05	7.38e-05	CcSEcCtD
Quinidine barbiturate—Myalgia—Epirubicin—hematologic cancer	4.4e-05	7.38e-05	CcSEcCtD
Quinidine barbiturate—Agitation—Doxorubicin—hematologic cancer	4.4e-05	7.37e-05	CcSEcCtD
Quinidine barbiturate—Anxiety—Epirubicin—hematologic cancer	4.39e-05	7.36e-05	CcSEcCtD
Quinidine barbiturate—Pruritus—Dexamethasone—hematologic cancer	4.39e-05	7.35e-05	CcSEcCtD
Quinidine barbiturate—Pruritus—Betamethasone—hematologic cancer	4.39e-05	7.35e-05	CcSEcCtD
Quinidine barbiturate—Skin disorder—Methotrexate—hematologic cancer	4.38e-05	7.34e-05	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.37e-05	7.33e-05	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Methotrexate—hematologic cancer	4.36e-05	7.31e-05	CcSEcCtD
Quinidine barbiturate—Vomiting—Triamcinolone—hematologic cancer	4.34e-05	7.28e-05	CcSEcCtD
Quinidine barbiturate—Rash—Triamcinolone—hematologic cancer	4.31e-05	7.22e-05	CcSEcCtD
Quinidine barbiturate—Dermatitis—Triamcinolone—hematologic cancer	4.3e-05	7.21e-05	CcSEcCtD
Quinidine barbiturate—Vertigo—Doxorubicin—hematologic cancer	4.3e-05	7.21e-05	CcSEcCtD
Quinidine barbiturate—Anorexia—Methotrexate—hematologic cancer	4.3e-05	7.21e-05	CcSEcCtD
Quinidine barbiturate—Syncope—Doxorubicin—hematologic cancer	4.29e-05	7.19e-05	CcSEcCtD
Quinidine barbiturate—Urticaria—Prednisone—hematologic cancer	4.29e-05	7.19e-05	CcSEcCtD
Quinidine barbiturate—Leukopenia—Doxorubicin—hematologic cancer	4.28e-05	7.18e-05	CcSEcCtD
Quinidine barbiturate—Headache—Triamcinolone—hematologic cancer	4.28e-05	7.17e-05	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Prednisone—hematologic cancer	4.27e-05	7.15e-05	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Prednisone—hematologic cancer	4.27e-05	7.15e-05	CcSEcCtD
Quinidine barbiturate—Confusional state—Epirubicin—hematologic cancer	4.26e-05	7.14e-05	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Dexamethasone—hematologic cancer	4.24e-05	7.11e-05	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Betamethasone—hematologic cancer	4.24e-05	7.11e-05	CcSEcCtD
Quinidine barbiturate—Palpitations—Doxorubicin—hematologic cancer	4.23e-05	7.09e-05	CcSEcCtD
Quinidine barbiturate—Oedema—Epirubicin—hematologic cancer	4.22e-05	7.08e-05	CcSEcCtD
Quinidine barbiturate—Hypotension—Methotrexate—hematologic cancer	4.22e-05	7.07e-05	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Doxorubicin—hematologic cancer	4.21e-05	7.05e-05	CcSEcCtD
Quinidine barbiturate—Shock—Epirubicin—hematologic cancer	4.15e-05	6.96e-05	CcSEcCtD
Quinidine barbiturate—Convulsion—Doxorubicin—hematologic cancer	4.15e-05	6.95e-05	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Epirubicin—hematologic cancer	4.14e-05	6.94e-05	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Epirubicin—hematologic cancer	4.13e-05	6.93e-05	CcSEcCtD
Quinidine barbiturate—Tachycardia—Epirubicin—hematologic cancer	4.12e-05	6.91e-05	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.11e-05	6.89e-05	CcSEcCtD
Quinidine barbiturate—Skin disorder—Epirubicin—hematologic cancer	4.1e-05	6.87e-05	CcSEcCtD
Quinidine barbiturate—Dizziness—Dexamethasone—hematologic cancer	4.1e-05	6.87e-05	CcSEcCtD
Quinidine barbiturate—Dizziness—Betamethasone—hematologic cancer	4.1e-05	6.87e-05	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Epirubicin—hematologic cancer	4.08e-05	6.84e-05	CcSEcCtD
Quinidine barbiturate—Chest pain—Doxorubicin—hematologic cancer	4.07e-05	6.83e-05	CcSEcCtD
Quinidine barbiturate—Myalgia—Doxorubicin—hematologic cancer	4.07e-05	6.83e-05	CcSEcCtD
Quinidine barbiturate—Arthralgia—Doxorubicin—hematologic cancer	4.07e-05	6.83e-05	CcSEcCtD
Quinidine barbiturate—Anxiety—Doxorubicin—hematologic cancer	4.06e-05	6.81e-05	CcSEcCtD
Quinidine barbiturate—Nausea—Triamcinolone—hematologic cancer	4.06e-05	6.8e-05	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.05e-05	6.78e-05	CcSEcCtD
Quinidine barbiturate—Anorexia—Epirubicin—hematologic cancer	4.02e-05	6.75e-05	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Methotrexate—hematologic cancer	4.02e-05	6.74e-05	CcSEcCtD
Quinidine barbiturate—Somnolence—Methotrexate—hematologic cancer	4.01e-05	6.72e-05	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Prednisone—hematologic cancer	3.98e-05	6.67e-05	CcSEcCtD
Quinidine barbiturate—Hypotension—Epirubicin—hematologic cancer	3.94e-05	6.61e-05	CcSEcCtD
Quinidine barbiturate—Vomiting—Betamethasone—hematologic cancer	3.94e-05	6.61e-05	CcSEcCtD
Quinidine barbiturate—Vomiting—Dexamethasone—hematologic cancer	3.94e-05	6.61e-05	CcSEcCtD
Quinidine barbiturate—Confusional state—Doxorubicin—hematologic cancer	3.94e-05	6.6e-05	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Methotrexate—hematologic cancer	3.92e-05	6.57e-05	CcSEcCtD
Quinidine barbiturate—Rash—Betamethasone—hematologic cancer	3.91e-05	6.55e-05	CcSEcCtD
Quinidine barbiturate—Rash—Dexamethasone—hematologic cancer	3.91e-05	6.55e-05	CcSEcCtD
Quinidine barbiturate—Oedema—Doxorubicin—hematologic cancer	3.91e-05	6.55e-05	CcSEcCtD
Quinidine barbiturate—Dermatitis—Betamethasone—hematologic cancer	3.9e-05	6.54e-05	CcSEcCtD
Quinidine barbiturate—Dermatitis—Dexamethasone—hematologic cancer	3.9e-05	6.54e-05	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.89e-05	6.53e-05	CcSEcCtD
Quinidine barbiturate—Headache—Betamethasone—hematologic cancer	3.88e-05	6.51e-05	CcSEcCtD
Quinidine barbiturate—Headache—Dexamethasone—hematologic cancer	3.88e-05	6.51e-05	CcSEcCtD
Quinidine barbiturate—Asthenia—Prednisone—hematologic cancer	3.87e-05	6.49e-05	CcSEcCtD
Quinidine barbiturate—Pain—Methotrexate—hematologic cancer	3.86e-05	6.47e-05	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.85e-05	6.45e-05	CcSEcCtD
Quinidine barbiturate—Shock—Doxorubicin—hematologic cancer	3.84e-05	6.44e-05	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Doxorubicin—hematologic cancer	3.83e-05	6.42e-05	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Doxorubicin—hematologic cancer	3.82e-05	6.41e-05	CcSEcCtD
Quinidine barbiturate—Pruritus—Prednisone—hematologic cancer	3.82e-05	6.4e-05	CcSEcCtD
Quinidine barbiturate—Tachycardia—Doxorubicin—hematologic cancer	3.81e-05	6.39e-05	CcSEcCtD
Quinidine barbiturate—Skin disorder—Doxorubicin—hematologic cancer	3.79e-05	6.36e-05	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Doxorubicin—hematologic cancer	3.78e-05	6.33e-05	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Epirubicin—hematologic cancer	3.76e-05	6.31e-05	CcSEcCtD
Quinidine barbiturate—Somnolence—Epirubicin—hematologic cancer	3.75e-05	6.29e-05	CcSEcCtD
Quinidine barbiturate—Anorexia—Doxorubicin—hematologic cancer	3.72e-05	6.24e-05	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Methotrexate—hematologic cancer	3.72e-05	6.23e-05	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Prednisone—hematologic cancer	3.69e-05	6.19e-05	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Methotrexate—hematologic cancer	3.69e-05	6.18e-05	CcSEcCtD
Quinidine barbiturate—Nausea—Betamethasone—hematologic cancer	3.68e-05	6.17e-05	CcSEcCtD
Quinidine barbiturate—Nausea—Dexamethasone—hematologic cancer	3.68e-05	6.17e-05	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Epirubicin—hematologic cancer	3.67e-05	6.15e-05	CcSEcCtD
Quinidine barbiturate—Hypotension—Doxorubicin—hematologic cancer	3.65e-05	6.12e-05	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.64e-05	6.11e-05	CcSEcCtD
Quinidine barbiturate—Pain—Epirubicin—hematologic cancer	3.61e-05	6.05e-05	CcSEcCtD
Quinidine barbiturate—Constipation—Epirubicin—hematologic cancer	3.61e-05	6.05e-05	CcSEcCtD
Quinidine barbiturate—Urticaria—Methotrexate—hematologic cancer	3.58e-05	6.01e-05	CcSEcCtD
Quinidine barbiturate—Dizziness—Prednisone—hematologic cancer	3.57e-05	5.98e-05	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Methotrexate—hematologic cancer	3.57e-05	5.98e-05	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Methotrexate—hematologic cancer	3.57e-05	5.98e-05	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.56e-05	5.97e-05	CcSEcCtD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL6—hematologic cancer	3.5e-05	0.000265	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—KRAS—hematologic cancer	3.49e-05	0.000265	CbGpPWpGaD
Quinidine barbiturate—Dyspnoea—Doxorubicin—hematologic cancer	3.48e-05	5.84e-05	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Epirubicin—hematologic cancer	3.48e-05	5.83e-05	CcSEcCtD
Quinidine barbiturate—Somnolence—Doxorubicin—hematologic cancer	3.47e-05	5.82e-05	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Epirubicin—hematologic cancer	3.45e-05	5.79e-05	CcSEcCtD
Quinidine barbiturate—Vomiting—Prednisone—hematologic cancer	3.43e-05	5.75e-05	CcSEcCtD
Quinidine barbiturate—Rash—Prednisone—hematologic cancer	3.4e-05	5.7e-05	CcSEcCtD
Quinidine barbiturate—Dermatitis—Prednisone—hematologic cancer	3.4e-05	5.7e-05	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Doxorubicin—hematologic cancer	3.4e-05	5.69e-05	CcSEcCtD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TNF—hematologic cancer	3.39e-05	0.000257	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ARHGEF12—hematologic cancer	3.39e-05	0.000257	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADCY7—hematologic cancer	3.39e-05	0.000257	CbGpPWpGaD
Quinidine barbiturate—Headache—Prednisone—hematologic cancer	3.38e-05	5.67e-05	CcSEcCtD
Quinidine barbiturate—KCNH2—Neuronal System—HRAS—hematologic cancer	3.38e-05	0.000256	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PTHLH—hematologic cancer	3.37e-05	0.000256	CbGpPWpGaD
Quinidine barbiturate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.37e-05	5.65e-05	CcSEcCtD
Quinidine barbiturate—Urticaria—Epirubicin—hematologic cancer	3.35e-05	5.62e-05	CcSEcCtD
Quinidine barbiturate—Pain—Doxorubicin—hematologic cancer	3.34e-05	5.6e-05	CcSEcCtD
Quinidine barbiturate—Constipation—Doxorubicin—hematologic cancer	3.34e-05	5.6e-05	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Epirubicin—hematologic cancer	3.34e-05	5.59e-05	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Epirubicin—hematologic cancer	3.34e-05	5.59e-05	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Methotrexate—hematologic cancer	3.32e-05	5.57e-05	CcSEcCtD
Quinidine barbiturate—CYP2D6—Metabolism—B3GAT1—hematologic cancer	3.32e-05	0.000252	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—DCK—hematologic cancer	3.32e-05	0.000252	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ASNS—hematologic cancer	3.32e-05	0.000252	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ARHGEF1—hematologic cancer	3.3e-05	0.00025	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PTGER4—hematologic cancer	3.28e-05	0.000249	CbGpPWpGaD
Quinidine barbiturate—Asthenia—Methotrexate—hematologic cancer	3.24e-05	5.43e-05	CcSEcCtD
Quinidine barbiturate—SCN5A—Developmental Biology—EP300—hematologic cancer	3.22e-05	0.000244	CbGpPWpGaD
Quinidine barbiturate—Feeling abnormal—Doxorubicin—hematologic cancer	3.22e-05	5.4e-05	CcSEcCtD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—hematologic cancer	3.21e-05	0.000243	CbGpPWpGaD
Quinidine barbiturate—Nausea—Prednisone—hematologic cancer	3.21e-05	5.37e-05	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.19e-05	5.35e-05	CcSEcCtD
Quinidine barbiturate—Pruritus—Methotrexate—hematologic cancer	3.19e-05	5.35e-05	CcSEcCtD
Quinidine barbiturate—CYP2D6—Metabolism—HDC—hematologic cancer	3.15e-05	0.000239	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—SRC—hematologic cancer	3.13e-05	0.000238	CbGpPWpGaD
Quinidine barbiturate—Hypersensitivity—Epirubicin—hematologic cancer	3.11e-05	5.21e-05	CcSEcCtD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.1e-05	0.000235	CbGpPWpGaD
Quinidine barbiturate—Urticaria—Doxorubicin—hematologic cancer	3.1e-05	5.2e-05	CcSEcCtD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCL3—hematologic cancer	3.1e-05	0.000235	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—HRAS—hematologic cancer	3.09e-05	0.000234	CbGpPWpGaD
Quinidine barbiturate—Body temperature increased—Doxorubicin—hematologic cancer	3.09e-05	5.18e-05	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Doxorubicin—hematologic cancer	3.09e-05	5.18e-05	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Methotrexate—hematologic cancer	3.09e-05	5.17e-05	CcSEcCtD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PTHLH—hematologic cancer	3.06e-05	0.000232	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—VEGFA—hematologic cancer	3.05e-05	0.000231	CbGpPWpGaD
Quinidine barbiturate—Asthenia—Epirubicin—hematologic cancer	3.03e-05	5.08e-05	CcSEcCtD
Quinidine barbiturate—SCN5A—Developmental Biology—STAT3—hematologic cancer	3.02e-05	0.000229	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NRAS—hematologic cancer	3.01e-05	0.000229	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—HRAS—hematologic cancer	3e-05	0.000227	CbGpPWpGaD
Quinidine barbiturate—Pruritus—Epirubicin—hematologic cancer	2.99e-05	5.01e-05	CcSEcCtD
Quinidine barbiturate—Dizziness—Methotrexate—hematologic cancer	2.98e-05	5e-05	CcSEcCtD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PTGER4—hematologic cancer	2.98e-05	0.000226	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AGRN—hematologic cancer	2.96e-05	0.000225	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCL17—hematologic cancer	2.96e-05	0.000225	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—IL6—hematologic cancer	2.96e-05	0.000224	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCR5—hematologic cancer	2.91e-05	0.00022	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ALB—hematologic cancer	2.91e-05	0.00022	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCR4—hematologic cancer	2.9e-05	0.00022	CbGpPWpGaD
Quinidine barbiturate—Diarrhoea—Epirubicin—hematologic cancer	2.89e-05	4.84e-05	CcSEcCtD
Quinidine barbiturate—SCN5A—Developmental Biology—MAPK3—hematologic cancer	2.89e-05	0.000219	CbGpPWpGaD
Quinidine barbiturate—Hypersensitivity—Doxorubicin—hematologic cancer	2.88e-05	4.82e-05	CcSEcCtD
Quinidine barbiturate—CYP2D6—Metabolism—CDA—hematologic cancer	2.88e-05	0.000218	CbGpPWpGaD
Quinidine barbiturate—Vomiting—Methotrexate—hematologic cancer	2.87e-05	4.81e-05	CcSEcCtD
Quinidine barbiturate—CHRM2—Signaling Pathways—LEF1—hematologic cancer	2.86e-05	0.000217	CbGpPWpGaD
Quinidine barbiturate—Rash—Methotrexate—hematologic cancer	2.84e-05	4.77e-05	CcSEcCtD
Quinidine barbiturate—Dermatitis—Methotrexate—hematologic cancer	2.84e-05	4.76e-05	CcSEcCtD
Quinidine barbiturate—Headache—Methotrexate—hematologic cancer	2.83e-05	4.74e-05	CcSEcCtD
Quinidine barbiturate—CHRM2—Signaling Pathways—GNA13—hematologic cancer	2.81e-05	0.000213	CbGpPWpGaD
Quinidine barbiturate—Asthenia—Doxorubicin—hematologic cancer	2.8e-05	4.7e-05	CcSEcCtD
Quinidine barbiturate—SCN5A—Developmental Biology—TGFB1—hematologic cancer	2.8e-05	0.000212	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IL3—hematologic cancer	2.8e-05	0.000212	CbGpPWpGaD
Quinidine barbiturate—Dizziness—Epirubicin—hematologic cancer	2.79e-05	4.68e-05	CcSEcCtD
Quinidine barbiturate—CYP2D6—Metabolism—PC—hematologic cancer	2.77e-05	0.00021	CbGpPWpGaD
Quinidine barbiturate—Pruritus—Doxorubicin—hematologic cancer	2.76e-05	4.63e-05	CcSEcCtD
Quinidine barbiturate—CHRM2—Signaling Pathways—TIAM1—hematologic cancer	2.76e-05	0.000209	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL6—hematologic cancer	2.74e-05	0.000208	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—RASGRP1—hematologic cancer	2.7e-05	0.000205	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—HRAS—hematologic cancer	2.69e-05	0.000204	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCL2—hematologic cancer	2.69e-05	0.000204	CbGpPWpGaD
Quinidine barbiturate—Vomiting—Epirubicin—hematologic cancer	2.68e-05	4.5e-05	CcSEcCtD
Quinidine barbiturate—Nausea—Methotrexate—hematologic cancer	2.68e-05	4.49e-05	CcSEcCtD
Quinidine barbiturate—CHRM2—Signaling Pathways—JAK3—hematologic cancer	2.68e-05	0.000203	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GBA—hematologic cancer	2.68e-05	0.000203	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC35B2—hematologic cancer	2.68e-05	0.000203	CbGpPWpGaD
Quinidine barbiturate—Diarrhoea—Doxorubicin—hematologic cancer	2.67e-05	4.48e-05	CcSEcCtD
Quinidine barbiturate—Rash—Epirubicin—hematologic cancer	2.66e-05	4.46e-05	CcSEcCtD
Quinidine barbiturate—Dermatitis—Epirubicin—hematologic cancer	2.66e-05	4.46e-05	CcSEcCtD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.65e-05	0.000201	CbGpPWpGaD
Quinidine barbiturate—Headache—Epirubicin—hematologic cancer	2.64e-05	4.43e-05	CcSEcCtD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCR4—hematologic cancer	2.63e-05	0.0002	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TNF—hematologic cancer	2.62e-05	0.000198	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—KRAS—hematologic cancer	2.59e-05	0.000197	CbGpPWpGaD
Quinidine barbiturate—Dizziness—Doxorubicin—hematologic cancer	2.58e-05	4.33e-05	CcSEcCtD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCR7—hematologic cancer	2.57e-05	0.000195	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCL13—hematologic cancer	2.57e-05	0.000195	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL3—hematologic cancer	2.54e-05	0.000193	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NCOR2—hematologic cancer	2.53e-05	0.000192	CbGpPWpGaD
Quinidine barbiturate—Nausea—Epirubicin—hematologic cancer	2.51e-05	4.2e-05	CcSEcCtD
Quinidine barbiturate—CHRM2—Signaling Pathways—CRKL—hematologic cancer	2.5e-05	0.00019	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL3RA—hematologic cancer	2.5e-05	0.00019	CbGpPWpGaD
Quinidine barbiturate—Vomiting—Doxorubicin—hematologic cancer	2.48e-05	4.16e-05	CcSEcCtD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.48e-05	0.000188	CbGpPWpGaD
Quinidine barbiturate—Rash—Doxorubicin—hematologic cancer	2.46e-05	4.13e-05	CcSEcCtD
Quinidine barbiturate—Dermatitis—Doxorubicin—hematologic cancer	2.46e-05	4.12e-05	CcSEcCtD
Quinidine barbiturate—CHRM2—Signaling by GPCR—RASGRP1—hematologic cancer	2.46e-05	0.000186	CbGpPWpGaD
Quinidine barbiturate—Headache—Doxorubicin—hematologic cancer	2.45e-05	4.1e-05	CcSEcCtD
Quinidine barbiturate—CYP2D6—Metabolism—MTAP—hematologic cancer	2.45e-05	0.000186	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GRB2—hematologic cancer	2.43e-05	0.000184	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RGS2—hematologic cancer	2.41e-05	0.000183	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TRIO—hematologic cancer	2.39e-05	0.000181	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CMA1—hematologic cancer	2.39e-05	0.000181	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TRH—hematologic cancer	2.39e-05	0.000181	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AGO2—hematologic cancer	2.34e-05	0.000177	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SPHK1—hematologic cancer	2.34e-05	0.000177	CbGpPWpGaD
Quinidine barbiturate—Nausea—Doxorubicin—hematologic cancer	2.32e-05	3.89e-05	CcSEcCtD
Quinidine barbiturate—CHRM2—Signaling Pathways—HDAC9—hematologic cancer	2.31e-05	0.000175	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LPAR1—hematologic cancer	2.31e-05	0.000175	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—HRAS—hematologic cancer	2.3e-05	0.000174	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—H3F3B—hematologic cancer	2.29e-05	0.000174	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GRB2—hematologic cancer	2.21e-05	0.000168	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—HRAS—hematologic cancer	2.21e-05	0.000167	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—FHL2—hematologic cancer	2.18e-05	0.000165	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CSF2—hematologic cancer	2.17e-05	0.000165	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AGRN—hematologic cancer	2.14e-05	0.000162	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PDE4B—hematologic cancer	2.13e-05	0.000161	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CNR2—hematologic cancer	2.13e-05	0.000161	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—IL6—hematologic cancer	2.11e-05	0.00016	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGF19—hematologic cancer	2.11e-05	0.00016	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PRKCG—hematologic cancer	2.1e-05	0.000159	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—JAK1—hematologic cancer	2.1e-05	0.000159	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RAC2—hematologic cancer	2.09e-05	0.000159	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DKK1—hematologic cancer	2.08e-05	0.000158	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STAT5B—hematologic cancer	2.06e-05	0.000156	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—IDH2—hematologic cancer	2.03e-05	0.000154	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HMMR—hematologic cancer	2.03e-05	0.000154	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADCY7—hematologic cancer	2e-05	0.000152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CSF2—hematologic cancer	1.97e-05	0.00015	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IL2RA—hematologic cancer	1.96e-05	0.000149	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—AKT1—hematologic cancer	1.95e-05	0.000148	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—XIAP—hematologic cancer	1.95e-05	0.000148	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ARNTL—hematologic cancer	1.91e-05	0.000145	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PRKCG—hematologic cancer	1.9e-05	0.000144	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—JAK1—hematologic cancer	1.9e-05	0.000144	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SMARCA4—hematologic cancer	1.9e-05	0.000144	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SH2B3—hematologic cancer	1.9e-05	0.000144	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GZMB—hematologic cancer	1.88e-05	0.000143	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CA9—hematologic cancer	1.85e-05	0.000141	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ACP5—hematologic cancer	1.85e-05	0.000141	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CTNNA1—hematologic cancer	1.84e-05	0.00014	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NCOR2—hematologic cancer	1.83e-05	0.000139	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EIF4EBP1—hematologic cancer	1.83e-05	0.000139	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCL3—hematologic cancer	1.83e-05	0.000139	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HSPB1—hematologic cancer	1.83e-05	0.000139	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTHLH—hematologic cancer	1.81e-05	0.000137	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SDC1—hematologic cancer	1.81e-05	0.000137	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL2RA—hematologic cancer	1.78e-05	0.000135	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTGER4—hematologic cancer	1.76e-05	0.000134	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LCK—hematologic cancer	1.75e-05	0.000133	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—IDH1—hematologic cancer	1.74e-05	0.000132	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TXN—hematologic cancer	1.72e-05	0.000131	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCC3—hematologic cancer	1.72e-05	0.000131	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTO1—hematologic cancer	1.72e-05	0.000131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—H3F3A—hematologic cancer	1.72e-05	0.00013	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SPHK1—hematologic cancer	1.69e-05	0.000128	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRKCZ—hematologic cancer	1.67e-05	0.000127	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CG—hematologic cancer	1.63e-05	0.000124	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—UGT1A1—hematologic cancer	1.62e-05	0.000123	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PARP1—hematologic cancer	1.61e-05	0.000122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FBXW7—hematologic cancer	1.59e-05	0.00012	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC22A1—hematologic cancer	1.58e-05	0.00012	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CRABP1—hematologic cancer	1.58e-05	0.00012	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HDAC2—hematologic cancer	1.56e-05	0.000118	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCR4—hematologic cancer	1.56e-05	0.000118	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALOX5—hematologic cancer	1.54e-05	0.000117	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CBL—hematologic cancer	1.52e-05	0.000115	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL3—hematologic cancer	1.5e-05	0.000114	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NUP98—hematologic cancer	1.49e-05	0.000113	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CG—hematologic cancer	1.48e-05	0.000112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTPN1—hematologic cancer	1.47e-05	0.000112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PTPN11—hematologic cancer	1.46e-05	0.00011	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RASGRP1—hematologic cancer	1.45e-05	0.00011	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HSP90AA1—hematologic cancer	1.45e-05	0.00011	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SYK—hematologic cancer	1.45e-05	0.00011	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ADCY7—hematologic cancer	1.44e-05	0.00011	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NCOA3—hematologic cancer	1.44e-05	0.00011	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CD—hematologic cancer	1.43e-05	0.000109	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NUP214—hematologic cancer	1.43e-05	0.000109	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CREB1—hematologic cancer	1.41e-05	0.000107	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCG2—hematologic cancer	1.41e-05	0.000107	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MTR—hematologic cancer	1.41e-05	0.000107	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STAT1—hematologic cancer	1.39e-05	0.000106	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCL2—hematologic cancer	1.38e-05	0.000105	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ENO2—hematologic cancer	1.38e-05	0.000105	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL6R—hematologic cancer	1.38e-05	0.000104	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3R1—hematologic cancer	1.35e-05	0.000103	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTT1—hematologic cancer	1.34e-05	0.000101	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—JAK2—hematologic cancer	1.32e-05	9.99e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MAP2K1—hematologic cancer	1.31e-05	9.95e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SDC1—hematologic cancer	1.31e-05	9.91e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRB2—hematologic cancer	1.3e-05	9.9e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CD—hematologic cancer	1.3e-05	9.88e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PDGFA—hematologic cancer	1.3e-05	9.87e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KITLG—hematologic cancer	1.28e-05	9.73e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STAT5A—hematologic cancer	1.25e-05	9.51e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CB—hematologic cancer	1.25e-05	9.48e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN2B—hematologic cancer	1.24e-05	9.43e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3R1—hematologic cancer	1.23e-05	9.33e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CD86—hematologic cancer	1.2e-05	9.12e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—JAK2—hematologic cancer	1.2e-05	9.07e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HES1—hematologic cancer	1.19e-05	8.99e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NCOR1—hematologic cancer	1.18e-05	8.94e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGF1—hematologic cancer	1.17e-05	8.84e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CSF2—hematologic cancer	1.17e-05	8.84e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	1.15e-05	8.71e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	1.15e-05	8.71e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	1.15e-05	8.7e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	1.14e-05	8.61e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	1.13e-05	8.56e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—JAK1—hematologic cancer	1.13e-05	8.53e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	1.13e-05	8.53e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CD44—hematologic cancer	1.11e-05	8.42e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NQO1—hematologic cancer	1.11e-05	8.42e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYCS—hematologic cancer	1.05e-05	7.97e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	1.05e-05	7.97e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	1.04e-05	7.92e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL2—hematologic cancer	1.04e-05	7.91e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TERT—hematologic cancer	1.04e-05	7.88e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	1.01e-05	7.69e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TSC2—hematologic cancer	9.91e-06	7.52e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	9.54e-06	7.23e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	9.44e-06	7.16e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTP1—hematologic cancer	9.26e-06	7.03e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ESR1—hematologic cancer	9.26e-06	7.02e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FN1—hematologic cancer	9.15e-06	6.94e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	9.04e-06	6.86e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—BAD—hematologic cancer	9.04e-06	6.86e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	8.95e-06	6.79e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CD80—hematologic cancer	8.77e-06	6.65e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCB1—hematologic cancer	8.77e-06	6.65e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	8.75e-06	6.64e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KIT—hematologic cancer	8.75e-06	6.64e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	8.75e-06	6.64e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	8.6e-06	6.52e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTM1—hematologic cancer	8.51e-06	6.46e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NCOR1—hematologic cancer	8.51e-06	6.46e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	8.38e-06	6.36e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CREB1—hematologic cancer	8.33e-06	6.32e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—BRAF—hematologic cancer	8.23e-06	6.24e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCL2—hematologic cancer	8.15e-06	6.18e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL6R—hematologic cancer	8.13e-06	6.17e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	8.12e-06	6.16e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	7.75e-06	5.88e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	7.7e-06	5.84e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	7.62e-06	5.78e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	7.53e-06	5.71e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MTHFR—hematologic cancer	7.52e-06	5.71e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGF2—hematologic cancer	7.37e-06	5.59e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	7.27e-06	5.51e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—JAK2—hematologic cancer	7.06e-06	5.36e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	6.92e-06	5.25e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MDM2—hematologic cancer	6.89e-06	5.23e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	6.71e-06	5.09e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MTOR—hematologic cancer	6.71e-06	5.09e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	6.4e-06	4.86e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CG—hematologic cancer	6.32e-06	4.79e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	6.3e-06	4.77e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	6.23e-06	4.72e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CASP3—hematologic cancer	6.17e-06	4.68e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL2—hematologic cancer	6.16e-06	4.67e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL6—hematologic cancer	6.13e-06	4.65e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCND1—hematologic cancer	6.01e-06	4.55e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—JUN—hematologic cancer	5.99e-06	4.55e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CREBBP—hematologic cancer	5.86e-06	4.45e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	5.81e-06	4.41e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTEN—hematologic cancer	5.8e-06	4.4e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	5.67e-06	4.3e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	5.66e-06	4.29e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CD—hematologic cancer	5.56e-06	4.21e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EP300—hematologic cancer	5.53e-06	4.19e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALB—hematologic cancer	5.49e-06	4.16e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SRC—hematologic cancer	5.38e-06	4.08e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3R1—hematologic cancer	5.25e-06	3.98e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	5.24e-06	3.97e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STAT3—hematologic cancer	5.18e-06	3.93e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NRAS—hematologic cancer	5.17e-06	3.92e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	4.95e-06	3.76e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CB—hematologic cancer	4.84e-06	3.67e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MYC—hematologic cancer	4.82e-06	3.65e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	4.81e-06	3.64e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KRAS—hematologic cancer	4.45e-06	3.38e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTEN—hematologic cancer	4.19e-06	3.17e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	4.09e-06	3.1e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—EP300—hematologic cancer	3.99e-06	3.03e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TP53—hematologic cancer	3.96e-06	3e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HRAS—hematologic cancer	3.78e-06	2.87e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL6—hematologic cancer	3.62e-06	2.75e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKT1—hematologic cancer	3.34e-06	2.53e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.95e-06	2.24e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AKT1—hematologic cancer	2.41e-06	1.83e-05	CbGpPWpGaD
